Hepatitis C virus hypervariable region 1 antibodies interrupt E2-SR-B1 interaction to suppress viral infection

Hepatitis C virus hypervariable region 1 antibodies interrupt E2-SR-B1 interaction to suppress viral infection

Summary: Whether hypervariable region 1 (HVR1)-targeting antibodies elicited during natural hepatitis C virus (HCV) infection contribute to virus clearance and what is the mechanism underlying remain unclear. Here, we demonstrated that treatment of HCV-infected hepatoma Huh7.5 cells with the IgGs pu...

Full description

Bibliographic Details
Main Authors:	Kai Deng, Qing Zhou, Zhanxue Xu, Yuhao Yang, Xi Liu, Chunna Li, Mingxiao Chen, Zhenzhen Zhang, Haihang Chen, Ling Ma, Muhammad Ikram Anwar, Changlong Zheng, Liang Rong, Mingxing Huang, Jinyu Xia, Yuanping Zhou, Yi-Ping Li
Format:	Article
Language:	English
Published:	Elsevier 2023-04-01
Series:	iScience
Subjects:	Immunology Virology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589004223004984

Similar Items

Exploring the impact of TGF-β superfamily cytokines on HIV-1 replication
by: Dickinson, M
Published: (2020)

Potent and broad neutralization of SARS-CoV-2 variants of concern (VOCs) including omicron sub-lineages BA.1 and BA.2 by biparatopic human VH domains
by: Chuan Chen, et al.
Published: (2022-08-01)

Limited TCR repertoire and ENTPD1 dysregulation mark late-stage COVID-19
by: Na Wang, et al.
Published: (2021-10-01)

Low levels of CIITA and high levels of SOCS1 predict COVID-19 disease severity in children and adults
by: Mònica Girona-Alarcon, et al.
Published: (2022-01-01)

Adoptive immune transfer from donors offers Anti-HBV protection to HBsAb-negative patients after Allo-HSCT
by: Jinhua Ren, et al.
Published: (2023-03-01)

Additional mutations based on Omicron BA.2.75 mediate its further evasion from broadly neutralizing antibodies
by: Huimin Guo, et al.
Published: (2023-04-01)

Efficient protection of mice from influenza A/H1N1pdm09 virus challenge infection via high avidity serum antibodies induced by booster immunizations with inactivated whole virus vaccine
by: Kayoko Sato, et al.
Published: (2019-01-01)

Reconstruction of a polyclonal ADCC antibody repertoire from an HIV-1 non-transmitting mother
by: Zak A. Yaffe, et al.
Published: (2023-05-01)

Transcriptional response modules characterize IL-1β and IL-6 activity in COVID-19
by: Lucy C.K. Bell, et al.
Published: (2021-01-01)

Selective SARS-CoV2 BA.2 escape of antibody Fc/Fc-receptor interactions
by: Yannic C. Bartsch, et al.
Published: (2023-05-01)

Molecular basis for antiviral activity of two pediatric neutralizing antibodies targeting SARS-CoV-2 Spike RBD
by: Yaozong Chen, et al.
Published: (2023-01-01)

Protein-protein conjugation enhances the immunogenicity of SARS-CoV-2 receptor-binding domain (RBD) vaccines
by: Puthupparampil V. Scaria, et al.
Published: (2022-08-01)

Monovalent and trivalent VSV-based COVID-19 vaccines elicit neutralizing antibodies and CD8+ T cells against SARS-CoV-2 variants
by: Kate A. Parham, et al.
Published: (2023-04-01)

An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer
by: Naveenchandra Suryadevara, et al.
Published: (2022-06-01)

GS-CA1 and lenacapavir stabilize the HIV-1 core and modulate the core interaction with cellular factors
by: Anastasia Selyutina, et al.
Published: (2022-01-01)

Standardized two-step testing of antibody activity in COVID-19 convalescent plasma
by: Pavlo Gilchuk, et al.
Published: (2022-01-01)

A real-world intention-to-treat analysis of a decade’s experience of treatment of hepatitis C with interferon-based therapies [version 1; referees: 2 approved]
by: Nowlan Selvapatt, et al.
Published: (2016-08-01)

Multi-targeted loss of the antigen presentation molecule MR1 during HSV-1 and HSV-2 infection
by: Carolyn Samer, et al.
Published: (2024-02-01)

19n01, a broadly neutralizing antibody against omicron BA.1, BA.2, BA.4/5, and other SARS-CoV-2 variants of concern
by: Melissa García-Vega, et al.
Published: (2023-04-01)

Prestimulation of CD2 confers resistance to HIV-1 latent infection in blood resting CD4 T cells
by: Sijia He, et al.
Published: (2021-11-01)

Innate immune recognition and evasion by viruses
by: Hertzog, J
Published: (2019)

Z-nucleic acids in virus-host interactions
by: Liverpool, L
Published: (2019)

Human Papillomavirus Type 16 L2 Gene Sequence Variation Analysis in Indonesian Cervical Cancer Specimens
by: Putra, Syandrez Prima, et al.
Published: (2022)

Oncolytic alphavirus replicons mediated recruitment and activation of T cells
by: Darshak K. Bhatt, et al.
Published: (2024-03-01)

Influenza A virus selectively elevates prostaglandin E2 formation in pro-resolving macrophages
by: Paul M. Jordan, et al.
Published: (2024-01-01)

HIV-exposed uninfected infants’ immune defects: From pathogen sensing, oxidative burst to antigens responses
by: Joel Fleury Djoba Siawaya, et al.
Published: (2023-12-01)

SARS-CoV-2 antigen-carrying extracellular vesicles activate T cell responses in a human immunogenicity model
by: Sarah E. Cummings, et al.
Published: (2024-01-01)

Unique immune profiles in collaborative cross mice linked to survival and viral clearance upon infection
by: Jessica B. Graham, et al.
Published: (2024-03-01)

Safety and immunogenicity of VLPCOV-02, a SARS-CoV-2 self-amplifying RNA vaccine with a modified base, 5-methylcytosine
by: Masayuki Aboshi, et al.
Published: (2024-02-01)

Regulatory T cells suppress the motility of cytotoxic T cells in Friend retrovirus–infected mice
by: Daniela Mittermüller, et al.
Published: (2023-07-01)

Human T cells efficiently control RSV infection
by: Chandrav De, et al.
Published: (2023-06-01)

NK cells contribute to reovirus-induced IFN responses and loss of tolerance to dietary antigen
by: Pamela H. Brigleb, et al.
Published: (2022-08-01)

Repeated exposure to heterologous hepatitis C viruses associates with enhanced neutralizing antibody breadth and potency
by: Nicole Frumento, et al.
Published: (2022-08-01)

Characterizing infection of B cells with wild-type and vaccine strains of measles virus
by: Logan Melot, et al.
Published: (2023-10-01)

Immunogenicity of COVID-19 vaccines and their effect on HIV reservoir in older people with HIV
by: Vitaliy A. Matveev, et al.
Published: (2023-10-01)

Glycosylated Delta-receptor-binding domain mucosal vaccine elicits broadly neutralizing antibodies with protection against SARS-CoV-2 challenge
by: Xiaoqing Guan, et al.
Published: (2023-10-01)

Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron
by: Jakob Kreye, et al.
Published: (2023-04-01)

Potent neutralizing broad-spectrum antibody against SARS-CoV-2 generated from dual-antigen-specific B cells from convalescents
by: Masaru Takeshita, et al.
Published: (2023-06-01)

HLA-DP diversity is associated with improved response to SARS-Cov-2 vaccine in hematopoietic stem cell transplant recipients
by: Juliette Villemonteix, et al.
Published: (2023-05-01)

Artificial intelligence-based HDX (AI-HDX) prediction reveals fundamental characteristics to protein dynamics: Mechanisms on SARS-CoV-2 immune escape
by: Jiali Yu, et al.
Published: (2023-04-01)